Cours suspendu

Transcripts Blueprint Medicines Corporation

Actions

BPMC

US09627Y1091

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/07/2025			Varia. 5j.	Varia. 1 janv.
129,46 ^USD	+0,14 %		-.--%	-

28/02	Blueprint Medicines présente des données sur quatre ans d'Ayvakit démontrant un bénéfice durable et une sécurité à long terme dans la mastocytose systémique indolente	CI
05/12	Bénéfices cliniques à long terme de l'avapritinib dans la mastocytose systémique : Blueprint Medicines présente de nouveaux résultats au congrès ASH 2025	CI

Transcripts

02/06/25	Transcript : Blueprint Medicines Corporation, Sanofi - M&A Call
01/05/25	Transcript : Blueprint Medicines Corporation, Q1 2025 Earnings Call, May 01, 2025
13/02/25	Transcript : Blueprint Medicines Corporation, Q4 2024 Earnings Call, Feb 13, 2025
13/01/25	Transcript : Blueprint Medicines Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 09:00 AM
30/10/24	Transcript : Blueprint Medicines Corporation, Q3 2024 Earnings Call, Oct 30, 2024
05/09/24	Transcript : Blueprint Medicines Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 01:50 PM
01/08/24	Transcript : Blueprint Medicines Corporation, Q2 2024 Earnings Call, Aug 01, 2024
10/06/24	Transcript : Blueprint Medicines Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM
02/05/24	Transcript : Blueprint Medicines Corporation, Q1 2024 Earnings Call, May 02, 2024
25/04/24	Transcript : Blueprint Medicines Corporation - Special Call
15/02/24	Transcript : Blueprint Medicines Corporation, Q4 2023 Earnings Call, Feb 15, 2024
08/01/24	Transcript : Blueprint Medicines Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 10:30 AM
26/10/23	Transcript : Blueprint Medicines Corporation, Q3 2023 Earnings Call, Oct 26, 2023
11/09/23	Transcript : Blueprint Medicines Corporation Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 11:20 AM
02/08/23	Transcript : Blueprint Medicines Corporation, Q2 2023 Earnings Call, Aug 02, 2023
14/06/23	Transcript : Blueprint Medicines Corporation Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 09:20 AM
22/05/23	Transcript : Blueprint Medicines Corporation - Special Call
04/05/23	Transcript : Blueprint Medicines Corporation, Q1 2023 Earnings Call, May 04, 2023
15/03/23	Transcript : Blueprint Medicines Corporation Presents at Barclays Global Healthcare Conference, Mar-15-2023 02:35 PM
27/02/23	Transcript : Blueprint Medicines Corporation - Special Call
16/02/23	Transcript : Blueprint Medicines Corporation, Q4 2022 Earnings Call, Feb 16, 2023
11/01/23	Transcript : Blueprint Medicines Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 04:30 PM
01/11/22	Transcript : Blueprint Medicines Corporation - Analyst/Investor Day
01/11/22	Blueprint Medicines Corporation fournit des prévisions de revenus pour 2022	CI
17/08/22	Transcript : Blueprint Medicines Corporation - Special Call